AI assistant
Sending…
PTC THERAPEUTICS, INC. — Director's Dealing 2024
May 8, 2024
31046_dirs_2024-05-08_68b53e5f-54f6-40f4-9ab0-223d32d35a8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2024-05-07
Reporting Person: Golden Lee Scott (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-07 | Common Stock | S | 175 | $32.82 | Disposed | 59813 | Direct |
Footnotes
F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 713 RSUs from a May 11, 2020 grant of 2,850 RSUs.
More from PTC THERAPEUTICS, INC.
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Board/Management Information
2026
Mar 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20